- Home
- ACTU vs EXOZ Comparison
ACTU vs EXOZ Comparison
Compare ACTU & EXOZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- EXOZ
- Stock Information
- Founded
- ACTU 2015
- EXOZ 2014
- Country
- ACTU United States
- EXOZ United States
- Employees
- ACTU N/A
- EXOZ N/A
- Industry
- ACTU
- EXOZ
- Sector
- ACTU
- EXOZ
- Exchange
- ACTU NYSE
- EXOZ NYSE
- Market Cap
- ACTU 135.0M
- EXOZ 138.0M
- IPO Year
- ACTU 2024
- EXOZ N/A
- Fundamental
- Price
- ACTU $8.00
- EXOZ $10.84
- Analyst Decision
- ACTU Strong Buy
- EXOZ
- Analyst Count
- ACTU 1
- EXOZ 0
- Target Price
- ACTU $20.00
- EXOZ N/A
- AVG Volume (30 Days)
- ACTU 42.0K
- EXOZ 8.7K
- Earning Date
- ACTU 05-21-2025
- EXOZ 05-15-2025
- Dividend Yield
- ACTU N/A
- EXOZ N/A
- EPS Growth
- ACTU N/A
- EXOZ N/A
- EPS
- ACTU N/A
- EXOZ N/A
- Revenue
- ACTU N/A
- EXOZ N/A
- Revenue This Year
- ACTU N/A
- EXOZ N/A
- Revenue Next Year
- ACTU N/A
- EXOZ N/A
- P/E Ratio
- ACTU N/A
- EXOZ N/A
- Revenue Growth
- ACTU N/A
- EXOZ N/A
- 52 Week Low
- ACTU $5.51
- EXOZ $8.50
- 52 Week High
- ACTU $11.73
- EXOZ $23.99
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- EXOZ N/A
- Support Level
- ACTU N/A
- EXOZ N/A
- Resistance Level
- ACTU N/A
- EXOZ N/A
- Average True Range (ATR)
- ACTU 0.00
- EXOZ 0.00
- MACD
- ACTU 0.00
- EXOZ 0.00
- Stochastic Oscillator
- ACTU 0.00
- EXOZ 0.00
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About EXOZ EXOZYMES INC
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.